Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Chugai Pharmaceutical Co. Ltd. (CHGCY)
Market Closed
17 Jul, 20:00
OTC PINK
All
(3)
DE
(2)
US
(1)
OTC PINK
Primary
XMUN
XFRA
$
22.
61
+0.31
+1.3901%
$
74.42B
Market Cap
-
P/E Ratio
1.7%
Div Yield
231,600
Volume
-
Eps
$
22.3
Previous Close
Watching
Watch
Add Transaction
Day Range
21.67
22.68
Year Range
19.5
34.84
Want to track
CHGCY
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Chugai Pharmaceutical Co. Ltd. (CHGCY) Statistics
Valuation metrics
Market Cap
74.42B
Enterprise value
11.65T
Trailing P/E (ttm)
26.66
Forward P/E
-
PEG ratio
2.6
Price/Sales (ttm)
9.34
Price/Book (mrq)
6.32
Enterprise Value/Revenue
9.03
Enterprise Value/EBITDA
17.55
Overview
Shares outstanding
1.65B
Float
639.89M
Shares short
-
% Held by insiders
-
% Held by institutions
0%
Average volume (10 days)
220.66K
Average volume (90 days)
267.41K
Price summary
52-Week low
19.5
52-Week high
34.84
Beta
0.6
50-Day moving average
23.1
200-Day moving average
27.06
Dividends and splits
Forward annual dividend rate
1.7
Forward annual dividend yield
0.0637%
Trailing annual dividend rate
106.5
Trailing annual dividend yield
0.0291%
5-Year annual dividend yield
1.95%
Payout ratio
0.99
Dividend Date
11 Apr 2025
Ex-Dividend Date
31 Dec 2024
Last split factor
12:1
Last split Date
6 Jul 2020
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2025
Profitability
Profit margin
0.35%
Operating margin
0.48%
Operational effectiveness
Return on assets
0.2%
Return on equity
0.23%
Income Statement
Revenue (ttm)
7.94B
Revenue per share (ttm)
392.29
Quarterly revenue growth (yoy)
0.15%
Gross profit (ttm)
5.64B
EBITDA
598.01B
Net income to common (ttm)
2.74B
Diluted EPS (ttm)
137.38
Quarterly earnings growth (yoy)
0.4%
Balance Sheet
Total cash (mrq)
6.18B
Total cash per share (mrq)
258.27
Total debt (mrq)
162.27M
Total Debt/Equity (mrq)
0.01
Current ratio (mrq)
4.7%
Book value per share (mrq)
579.59
Cash Flow
Cash flow statement
2.44B
Levered free cash flow (LFCF)
1.66B